Chemocentryx Competitors

CCXI -  USA Stock  

USD 17.19  0.11  0.64%

Chemocentryx competes with Dynavax Technologies, and Dyadic International; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Chemocentryx competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Chemocentryx to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Chemocentryx competition on your existing holdings. Continue to Chemocentryx Correlation with its peers.

Search Competition 

 
Refresh
The current Return on Investment is estimated to decrease to -24.01. The current Return on Average Assets is estimated to decrease to -0.13. Chemocentryx Assets Non Current are most likely to increase significantly in the upcoming years. The last year's value of Assets Non Current was reported at 77.33 Million. The current Revenue to Assets is estimated to increase to 0.18, while Return on Average Assets are projected to decrease to (0.13) .

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Chemocentryx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Chemocentryx in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
13.8916.9720.05
Details
Intrinsic
Valuation
LowReal ValueHigh
15.4721.9225.00
Details
Naive
Forecast
LowNext ValueHigh
14.0417.1120.19
Details
6 Analysts
Consensus
LowTarget PriceHigh
14.0027.6751.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Chemocentryx. Your research has to be compared to or analyzed against Chemocentryx's peers to derive any actionable benefits. When done correctly, Chemocentryx's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Chemocentryx.

Chemocentryx Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Chemocentryx and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Chemocentryx and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Chemocentryx does not affect the price movement of the other competitor.
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.

Cross Equities Net Income Analysis

Compare Chemocentryx and related stocks such as Dynavax Technologies, and Dyadic International Net Income Over Time
Select Fundamental

201020112012201320142015201620172018201920202021
DVAX
(57.3 M)(48.6 M)(69.9 M)(66.7 M)(90.7 M)(106.8 M)(112.4 M)(95.2 M)(158.9 M)(152.6 M)(75.2 M)(81.2 M)
DYAI
(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(3.6 M)(2.1 M)(5.7 M)(8.3 M)(9.3 M)(9.6 M)

Chemocentryx and related stocks such as Dynavax Technologies, and Dyadic International Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Chemocentryx financial statement analysis. It represents the amount of money remaining after all of Chemocentryx operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Chemocentryx Competitive Analysis

The better you understand Chemocentryx competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Chemocentryx's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Chemocentryx's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CCXI
DVAX
DYAI
 0.64 
 17.19 
Chemocentryx
 18.92 
 18.79 
Dynavax
 2.09 
 5.62 
Dyadic
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Total Asset
Short Ratio
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Chemocentryx Competition Performance Charts

Complement your Chemocentryx position

In addition to having Chemocentryx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Basic Utilities Thematic Idea Now

Basic Utilities
Basic Utilities Theme
Companies involved in production and distribution of electric, gas, water, and other energy utilities. Basic Utilities theme has 30 constituents.
View All  Next Launch Basic Utilities
Continue to Chemocentryx Correlation with its peers. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.